Professional Overview
Frank Hurst currently serves as a Medical Director at IQVIA since June 2023. He is a nephrologist with a substantial regulatory and clinical background, uniquely combining medical expertise with business acumen, currently pursuing an MBA (2021–2024) from the Questrom School of Business, Boston University. He is based in Kailua-Kona, Hawaii, United States, and maintains a notable LinkedIn presence ([linkedin.com/in/frank-hurst-7366bb80](https://www.linkedin.com/in/frank-hurst-7366bb80)).
Current Role and Responsibilities
At IQVIA, he holds the title of Medical Director, a role he has occupied since mid-2023. His work aligns with the clinical and regulatory aspects of nephrology, dialysis, and extracorporeal therapies, contributing to innovation and strategic oversight in medical devices and drug development for renal care. He actively engages in applying advanced analytics and AI-driven solutions to streamline clinical development within the healthcare data and technology context that IQVIA operates.
Consulting and Adjunct Roles
In May 2024, Frank additionally assumed the role of Regulatory Strategy Consultant at GAC Consulting LLC, where he applies his expertise in regulatory review specifically within nephrology, dialysis, and extracorporeal therapies. His consulting includes strategic advisory on devices, drugs, and combination products, underlining his strong regulatory knowledge and experience.
Simultaneously, he continues longstanding clinical and academic roles:
- Staff Nephrologist at Walter Reed National Military Medical Center (since September 2011), based in Bethesda, Maryland, providing clinical care and nephrology expertise to this premier military medical institution.
- Associate Professor (Adjunct) of Medicine at Uniformed Services University of the Health Sciences since July 2007, contributing to academic medicine and teaching in nephrology and related medical disciplines.
Previous Experience and Expertise
Frank Hurst’s extensive career includes:
- Nearly 12 years (August 2011–June 2023) as a Clinical Reviewer/Medical Officer at the U.S. Food and Drug Administration (FDA) within the Center for Devices and Radiological Health (CDRH), specifically in the Division of Cardiology and Nephrology (DCN) and the Renal and Transplantation Devices Team. His focus included oversight of nephrology-related devices and treatments, regulatory evaluation, and clinical assessment.
- Over 4 years as Medical Director of the Nephrology Clinic and Infusion Services, and Director of Performance Improvement at Walter Reed Army Medical Center (July 2007–August 2011).
- Service as Battalion Surgeon for the 10th Mountain Division in the U.S. Army (March–December 2008), demonstrating leadership in military medicine.
- Training through an Internal Medicine Residency and Nephrology Fellowship at Tripler Army Medical Center (2002–2007), consolidating his clinical foundation in nephrology and internal medicine.
Academic Credentials
- MBA (expected 2024), Questrom School of Business, Boston University
- MD (2002), Virginia Commonwealth University School of Medicine
- BS in Biology (1998), College of William & Mary
- Undergraduate studies at Virginia Wesleyan University (1994–1996)
Certifications
- Board Certified in Nephrology, American Board of Internal Medicine (Issued January 2007, valid through January 2027)
- Board Certified in Internal Medicine, American Board of Internal Medicine (Issued January 2005, valid through January 2025)
Research, Publications, and Thought Leadership
Frank Hurst has authored and contributed to at least 10 research publications within nephrology and related regulatory science, collectively cited over 300 times. His research topics include patient risk tolerance in wearable dialysis devices, clinical outcomes post-transplantation, and registry development for patient-centered venous access care. His work reflects a strong orientation toward leveraging data and patient-centered approaches to improve renal and transplant device regulation and therapy outcomes.
He is actively engaged in key nephrology and clinical research forums and has been involved in editorial roles within nephrology journals and clinical guideline development. His historical contributions also include leadership in advancing regulatory pathways for nephrology devices and combination therapies, facilitating progress in rare and underserved patient communities.
Industry Recognition and Influence
- Former senior medical officer at FDA CDER with close to 12 years of service
- Recognized as an American Society of Nephrology (ASN) Fellow
- Has received internal recognition for innovation and leadership, including awards for promoting AI and advanced analytics in clinical research settings
- Maintains active professional engagement with over 600 LinkedIn followers and a broad professional network spanning clinical, regulatory, academic, and consulting sectors
Strategic Insights Relevant to IQVIA
Frank Hurst’s profile demonstrates his strategic positioning at the intersection of clinical nephrology, regulatory science, and healthcare innovation. His dual roles as Medical Director at IQVIA and regulatory consultant highlight his capability to influence the development, evaluation, and commercialization of nephrology-related healthcare solutions. His ongoing MBA education suggests further strengthening of his leadership and business strategy skills, which complements IQVIA’s focus on data-driven healthcare solutions and AI innovations.
Partnering or engaging with Frank offers access to deep domain expertise in nephrology devices and therapeutics, extensive regulatory knowledge from FDA tenure, and active involvement in military and academic healthcare networks. His experience managing complex clinical environments and regulatory challenges aligns well with IQVIA’s portfolio in real-world evidence generation, clinical development, and regulatory strategy.
Profile Image: 
LinkedIn: https://www.linkedin.com/in/frank-hurst-7366bb80
Location: Kailua-Kona, Hawaii, USA
This report consolidates verified professional data up to 2025, emphasizing Frank Hurst’s current role at IQVIA and his extensive nephrology and regulatory expertise valuable for healthcare strategy contexts focused on renal device and drug development.
